Jeffrey Weber
MD, PhD
Deputy Director of Laura and Isaac Perlmutter Cancer Center
👥Biography 个人简介
Jeffrey Weber led CheckMate-238 demonstrating superiority of adjuvant nivolumab over ipilimumab for resected stage IIIB-IV melanoma with improved recurrence-free survival and better tolerability. His work established nivolumab as preferred adjuvant anti-PD-1 and shaped sequential IO strategies. He continues biomarker research in adjuvant melanoma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Jeffrey Weber 的研究动态
Follow Jeffrey Weber's research updates
留下邮箱，当我们发布与 Jeffrey Weber（NYU Langone Health）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment